SEC 13F Intelligence

Delta Investment Management, LLC / ALNY

Delta Investment Management, LLC’s Alnylam Pharmaceuticals Inc Position

Does Delta Investment Management, LLC own Alnylam Pharmaceuticals Inc (ALNY)? Not currently — the last reported position was 18.0K shares worth $3M in Q2 2020; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$3M
Q2 2020
Shares
18.0K
% of Portfolio
+1.11%
Quarters Held
2
position exited

Position History ALNY

Reported value by quarter
Q4 ’19: $2MQ4 ’19Q2 ’20: $3MQ2 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202018.0K$3M+1.11%
Q4 201920.5K$2M+0.86%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Delta Investment Management, LLC’s full portfolio or all institutional holders of ALNY.